OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS
2019
Purpose:Mitogen-activates protein kinase (MAPK) inhibitors, particularly MEK inhibitors, have shifted the treatment paradigm for metastatic BRAF-mutant cutaneous melanoma; however, oncologists, ophthalmologists, and patients have noticed different toxicities of variable importance. This review aims
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
112
References
23
Citations
NaN
KQI